1265PPhase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapyAntoni Ribas,I Mehmi,Theresa Medina,Christopher D. Lao,S Kummar,Asim Amin,S. Deva,April K. Salama,T Tueting,Mohammed M. Milhem,Christopher J. Hoimes,Gregory A. Daniels,Montaser Shaheen,S Jang,M Barve, A Powell,S Chandra,Emmett V. Schmidt,Robert S. JanssenANNALS OF ONCOLOGY（2018）引用 6|浏览75暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
